NEW YORK (GenomeWeb News) - Novartis will use Digilab BioVision's Peptidomics technology to quantitatively characterize peptides in biological samples for biomarker discovery, Digilab announced earlier this month.
The agreement renews a deal Novartis and Digilab penned in 2004. Digilab will receive a research payment, milestone payments, and royalties under the new agreement, Digilab said.
No further financial details were disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.